Churg–Strauss Syndrome

Chapter

Abstract

Of all the vasculitides, Churg–Strauss Syndrome (CSS) is one of the least common. Though regarded as an ANCA-associated vasculitis, serologies may be negative in a high proportion of patients. As a systemic disorder, disease presentation may be highly variable. Here we discuss two challenging cases of CSS.

Keywords

Vasculitis Pulmonary eosinophilia Asthma Churg–Strauss syndrome 

References

  1. 1.
    Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27(2):277–301.PubMedGoogle Scholar
  2. 2.
    Baldini C, Talarico R, Della Rossa A, Bombardieri S. Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am. 2010;36(3):527–43.PubMedCrossRefGoogle Scholar
  3. 3.
    Vaglio A, Moosig F, Zwerina J. Churg-Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol. 2012;24(1):24–30.PubMedCrossRefGoogle Scholar
  4. 4.
    Orriols R, Munoz X, Ferrer J, Huget P, Morell F. Cocaine-induced Churg-Strauss vasculitis. Eur Respir J. 1996;9(1):175–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome A prospective study in 342 patients. Medicine (Baltimore). 1996;75(1):17–28.CrossRefGoogle Scholar
  6. 6.
    Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90(1):19–27.CrossRefGoogle Scholar
  7. 7.
    Kane GC, Keogh KA. Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol. 2009;21(1):29–34.PubMedCrossRefGoogle Scholar
  8. 8.
    Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–100.PubMedCrossRefGoogle Scholar
  9. 9.
    Vaglio A, Strehl JD, Manger B, et al. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. 2012;71(3):390–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Pepper RJ, Fabre MA, Pavesio C, et al. Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatology (Oxford). 2008;47(7):1104–5.CrossRefGoogle Scholar
  11. 11.
    Casian A, Jayne D. Plasma exchange in the treatment of Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis. Curr Opin Rheumatol. 2011;23(1):12–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Division of Pulmonary, Critical Care & Sleep Medicine, Department of Internal MedicineUC Davis Medical Center and UC Davis Asthma Network (UCAN)SacramentoUSA

Personalised recommendations